# HyperBranch Medical Technology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hyperbranch-medical-technology

- Industry: Medical Devices & Equipment
- Headquarters: Raleigh, US
- Website: www.hyperbranch.com
- Total disclosed funding: $7.7M
- Latest round: Series B (Jun 4, 2012)
- Investors on record: 2

## About

HyperBranch Medical Technology Inc. is a biotechnology company specializing in innovative medical devices that enhance surgical procedures through advanced hydrogel technology.HyperBranch Medical Technology Inc. is focused on developing medical devices designed for dural repair. Founded in 2003, it is headquartered in Raleigh, US. In October 2018, Stryker Corporation acquired the company for USD 220 mn. The company has completed 10 deals in total.HyperBranch Medical Technology Inc. offers the Adherus AutoSpray and Adherus AutoSpray ET Dural Sealants, which are hydrogel-based products designed to assist in dural repair procedures. These sealants serve as adjuncts to traditional suturing, ensuring watertight closure during cranial surgeries and are utilized in various surgical environments to prevent cerebrospinal fluid leaks.Revenue is generated through the direct sales of the Adherus AutoSpray and Adherus AutoSpray ET Dural Sealants to healthcare institutions. These are sold on a B2B basis, focusing on hospitals and surgical facilities that incorporate these products into their surgical practices, ensuring effective dural repairs and advancing surgical outcomes in neurosurgery.The acquisition by Stryker Corporation is expected to bolster HyperBranch's market presence and product development. Future growth plans include the introduction of new products and the expansion into additional markets in the healthcare sector. The recent funding from the acquisition will support these initiatives, aiming to enhance surgical solutions globally.

## Funding rounds

- Series B, Jun 4, 2012, $1.7M — Aurora Funds
- Series A, Jan 25, 2005, $6M — Aurora Funds, H.I.G. BioHealth Partners

## Investors

- Aurora Funds (https://capitalatlas.ai/funds/aurora-funds) — Series A, Series B
- H.I.G. BioHealth Partners (https://capitalatlas.ai/funds/h-i-g-biohealth-partners) — Series A